JPRN-UMIN000035143已完成未知
Investigation of efficacy of levocarnitine intravenous formulation in patients undergoing hemodialysis - Levocarnitine study
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 96
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •doctor's judgement, patient who did not agree with the investigation
研究者
相似试验
已完成
不适用
Prevalence rate of carnitine and zinc deficiency and the efficacy of levocarnitine injection therapy in dialysis patients with renal anemiaEnd-stage kidney disease undergoing hemodialysis or peritoneal dialysis with renal anemia.JPRN-UMIN000025327ihon University School of Medicine90
已完成
3 期
Assessment of Intravenous Levocarnitine on the mortality and morbidity of patients with aluminum phosphide intoxicatioaluminum phosphide poisoning.Toxic effect of pesticidesIRCT20210720051946N1Shahid Beheshti University of Medical Sciences40
已完成
不适用
Clinical efficacy of levocarnitine supplementation in patients with hemodialysisHemodialysis patientsJPRN-UMIN000015185Keiai Hospital100
已完成
不适用
Efficacy of levocarnitine as an add-on treatment to branched-chain amino acid-enriched nutritional supplementation on liver cirrhosis complicated by hepatic encephalopathy -a open-label studyiver cirrhosisJPRN-UMIN000012096Faculty of Medical Sciences, University of Fukui40
尚未招募
2 期
The effect of intravenous L-carnitine supplementation during oxaliplatin based chemotherapy on blood- and urinary levels of carnitineCarnitine metabolisme, excretie, deficiëntie, interactie met chemotherapie (oxaliplatin)Deficiency/lack of/reduction of concentration of carnitine (an amino acid or half-vitamin) during/caused by treatment with chemotherapy (oxaliplatin)10013317NL-OMON48693Maxima Medisch Centrum10